Engler, Kim
Toupin, Isabelle
Vicente, Serge
Ahmed, Sara
Lebouché, Bertrand
Funding for this research was provided by:
Canadian HIV Trials Network, Canadian Institutes of Health Research (CTN283)
Merck Canada (IISP-53538)
CIHR Strategy for Patient-Oriented Research -Quebec Support Unit (M006)
Article History
Received: 3 December 2018
Accepted: 8 May 2019
First Online: 27 June 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: KE and BL are co-principal investigators of a study to develop a new PROM of patient-identified barriers to ART adherence with significant stakeholder engagement (the I-Score Study, clinicaltrials.gov identifier: NCT02586584).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.